Oncology Institute Cash Flow Statement (2020-2026) | TOIIW

Cash Flow Statement Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026
Operating Activities
Net Income (Quarter)
3.21M-2.98M-10.16M19.29M-5.45M-2.67M-11.01M-30.00M-16.90M-17.42M-18.75M-19.89M-15.48M-16.11M-13.18M-19.59M-17.01M-16.50M-7.51M-2.49M
Depreciation and Depletion (Quarter)
0.17M0.23M0.26M0.31M0.36M0.39M0.46M0.54M0.60M0.91M0.81M0.71M0.74M0.80M0.93M1.01M1.03M1.01M0.92M0.90M
Share-based Compensation (Quarter)
0.05M0.06M24.38M8.55M6.51M6.55M6.07M4.96M4.11M4.66M4.08M4.09M3.39M2.39M1.29M1.46M0.75M1.02M1.32M1.69M
Deferred Taxes (Quarter)
-3.76M2.30M0.18M-0.05M0.05M-0.45M-0.03M-0.00M0.08M-0.13M
Gains from Investment Securities (Quarter)
0.01M-2.06M0.16M0.43M-0.75M-0.12M-0.02M0.03M-0.55M-0.02M-0.65M0.00M0.05M0.15M0.02M-0.17M
Asset Writedowns and Impairment (Quarter)
-0.72M0.06M0.25M0.15M0.10M0.14M0.07M0.00M-0.00M0.03M1.99M
Cash from Operations (Quarter)
-7.13M-2.68M-23.34M-16.98M-10.38M-20.40M-14.00M-15.45M-8.66M-8.31M-3.89M-15.88M-15.66M0.82M4.00M-4.99M-10.20M-12.63M3.23M-2.21M
Depreciation, Depletion & Amortization
Amortization of Goodwill (Quarter)
9.94M16.87M
Amortizatization of Intangibles (Quarter)
0.03M0.99M0.92M0.67M-0.88M1.92M0.32M0.13M0.05M0.00M
Amortization of Deferred Charges (Quarter)
0.02M0.02M0.89M1.55M1.52M1.54M1.57M1.57M1.56M1.56M1.59M1.59M4.87M1.13M1.17M1.21M1.21M
Depreciation & Amortization (CF) (Quarter)
0.79M0.85M0.92M0.99M1.10M1.13M1.19M1.27M1.33M1.70M1.58M1.49M1.52M1.57M1.71M1.78M1.80M1.72M1.63M1.62M
Change in Working Capital
Change in Receivables (Quarter)
1.24M-1.48M0.47M4.66M-5.47M0.14M20.96M-0.19M6.76M2.08M-4.09M-0.18M-0.02M12.34M-6.17M0.23M12.72M-0.64M-0.86M
Change in Inventory (Quarter)
0.28M1.07M0.50M1.33M0.40M0.85M-0.85M0.99M1.91M0.01M1.47M-2.12M-0.23M-1.22M-0.07M2.27M3.48M3.10M-2.01M7.42M
Change in Account Payables (Quarter)
0.48M5.30M-3.33M-2.96M1.30M-2.75M-1.78M2.57M1.18M0.21M1.10M6.36M-5.46M7.58M0.74M5.06M6.43M0.44M7.71M4.61M
Change in Accured Expenses (Quarter)
1.13M-0.06M-4.52M0.53M2.04M0.33M-0.55M-0.81M2.15M-0.77M2.78M5.37M-3.39M2.84M4.66M2.57M-0.30M0.13M-2.84M3.92M
Change in Taxes (Quarter)
0.53M4.38M-6.03M0.26M-0.13M-0.00M-0.26M
Other Working Capital Changes (Quarter)
0.39M-0.42M9.12M-0.91M0.91M-1.07M-2.73M0.02M-2.55M-0.20M-0.40M-0.08M-0.09M-0.04M0.00M0.00M-0.12M-0.15M0.26M-0.14M
Investing Activities
Capital Expenditures (Quarter)
0.41M0.95M0.87M1.00M1.34M1.19M-3.53M1.84M0.94M0.93M0.86M0.61M1.83M-0.40M1.75M0.33M1.21M0.60M1.06M1.04M
Sales of Property, Plant and Equipment (Quarter)
0.13M
Acquisitions (Quarter)
8.28M8.92M-0.81M0.47M0.16M
Change in Acquisitions & Divestments (Quarter)
30.00M30.13M8.57M12.56M20.00M20.00M10.00M
Cash from Investing Activities (Quarter)
-0.61M-0.95M-9.15M-1.00M-10.26M-87.78M-32.57M18.40M24.90M7.71M11.63M19.39M18.18M10.40M-1.75M-0.20M-1.21M-0.60M-1.06M-1.04M
Financing Activities
Other financing activities (Quarter)
Cash from Financing Activities (Quarter)
-4.51M-0.01M136.13M-1.66M-10.69M105.39M-0.85M-1.71M-2.60M-0.76M-1.78M-0.94M-2.15M-0.24M-0.16M-4.74M1.96M10.60M3.73M-0.03M
Additional items
Change in Cash (Quarter)
-12.24M-3.64M103.64M-19.64M-31.33M-2.78M-47.41M1.24M13.64M-1.36M5.95M2.57M0.37M10.98M2.27M-9.93M-9.45M-2.63M5.91M-3.29M
Free Cash Flow (Quarter)
-7.54M-3.63M-24.21M-17.98M-11.72M-21.59M-10.46M-17.29M-9.60M-9.24M-4.75M-16.49M-17.49M1.22M2.25M-5.32M-11.41M-13.23M2.17M-3.26M
Net Cash Flow (Quarter)
-12.24M-3.64M103.64M-19.64M-31.33M-2.78M-47.41M1.24M13.64M-1.36M5.95M2.57M0.37M10.98M2.08M-9.93M-9.45M-2.63M5.91M-3.29M